Dr Robin Grant is a Consultant Neurologist and Honorary Senior Lecturer specialising in Neuro-oncology.
Brain and spinal cord tumour clinical research is also about international collaboration and friendship with colleagues in other countries working in the same clinical research and clinical trials areas.
Recent multi-centre clinical trials using bevacizumab (Gilbert et al 2014 and Chinot et al 2014) were only possible through collaboration and use of agreed imaging measures (Macdonald Criteria), important symptomatic and Quality of Life measures and systematic evaluation of outcomes.
Management of symptoms of primary brain tumour and the side effects of treatment are of major importance to patients, with the most common complaints in the clinic being fatigue, cognitive problems (especially poor memory), mood related issues, fear of the tumour coming back and seizures.
Drugs used to treat these symptoms may interfere positively (help) or negatively (hinder) with the ability of chemotherapies and other treatments to be effective at treating the tumour. These important drug-drug interactions are the focus of Dr Grant’s clinical research along with evidence based evaluation of therapies.